Fien A. von Meijenfeldt

Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report

Axel Rosell, Sebastian Havervall, Fien A. von Meijenfeldt et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2020 · 220 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +12

Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19

Henry Ng, Sebastian Havervall, Axel Rosell et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2020 · 217 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +16

Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge

Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer et al. · Blood Advances · 2021 · 130 citations · Full text

Medicine, Hematology, Pathology +17

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation

Annabel Blasi, Fien A. von Meijenfeldt, Jelle Adelmeijer et al. · Journal of Thrombosis and Haemostasis · 2020 · 125 citations · Full text

Medicine, Hematology, Hematopathology +16

Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality

Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer et al. · Research and Practice in Thrombosis and Haemostasis · 2020 · 88 citations · Full text

Medicine, Hematology, Infectious Diseases +13